| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20026922 | HPV | ENSG00000167723.15 | protein_coding | TRPV3 | No | No | 162514 | B2KYM6 Q8NET8 |
| TVIS20053258 | HPV | ENSG00000167723.15 | protein_coding | TRPV3 | No | No | 162514 | B2KYM6 Q8NET8 |
| TVIS20043395 | HPV | ENSG00000167723.15 | protein_coding | TRPV3 | No | No | 162514 | B2KYM6 Q8NET8 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | TRPV3 |
|---|---|
| DrugBank ID | DB11345 |
| Drug Name | (S)-camphor |
| Target ID | BE0003416 |
| UniProt ID | Q8NET8 |
| Regulation Type | agonist |
| PubMed IDs | 16192383; 23625413 |
| Citations | Xu H, Blair NT, Clapham DE: Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J Neurosci. 2005 Sep 28;25(39):8924-37. doi: 10.1523/JNEUROSCI.2574-05.2005.@@Sherkheli MA, Vogt-Eisele AK, Weber K, Hatt H: Camphor modulates TRPV3 cation channels activity by interacting with critical pore-region cysteine residues. Pak J Pharm Sci. 2013 May;26(3):431-8. |
| Groups | Experimental |
| Direct Classification | Bicyclic monoterpenoids |
| SMILES | CC1(C)[C@H]2CC[C@]1(C)C(=O)C2 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL2252949 |
